118-Year Old Woman From Madhya Pradesh Becomes The Oldest Woman To Get COVID-19 Vaccine
Tulsabai, possibly the oldest woman in the world has received a COVID-19 vaccine shot. She claims that there are no side effects and also urges people to take it at the earliest.
In India, 118-year-old Tulsabai becomes the oldest woman to be given the COVID-19 vaccine. The health department on 5 April said that citing Tulsabai’s Aadhar card details, she is 118-year-old and becomes the oldest woman in MP to get vaccinated. Tulsabai, possibly the oldest in the world to receive a COVID-19 shot has not shown any side effects from the vaccine dosage so far as told in her interview.
“The woman who has been vaccinated has not complained of any side effects, so far,” Dipak Singh, District Collector said. She was administered the dose at an inoculation facility in the Khimlasa area in the Sagar district on 3 April. Soon after Tulsaibai got her vaccine shot, she stepped out of the health facility and shown a victory sign to the media.
In her Bundelkhendi dialect, she said, “Hamne lagwao teeka so ache hojen. So tum bhi lagwaao so ache ho ja ho. Kuchhu dikkat nainuaan…(I took the vaccine so that I feel better. You should also take it so that you feel better. There are no troubles at all).”
According to her Aadhaar card, Tulsabai was born on January 1, 1913. She is a resident of the Sadarpur area of Sagar, a part of the Bundelkhand region as the media reports suggest.
The Centre expanded the nationwide vaccination drive to include everyone above the age of 45 from 1 April. The Centre also issued a warning that the situation is going from “bad to worse” and urged states to achieve 100 per cent vaccination coverage of those above the age of 45 years in districts that are seeing a rise in the number of cases within the next two weeks.
India started its second COVID-19 vaccination drive to inoculate people above 60 years and those over 45 with severe conditions against coronavirus from 1 March. The first phase of the world’s largest inoculation drive started on January 16 with two vaccines – Covishield (Oxford-AstraZeneca’s vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited).